The ICMR is seeking pharmaceutical partners to commercialize a novel liquid formulation that reduces infant brain toxins by 85%, offering an easy, low-cost alternative to phototherapy and blood transfusions.
from mint - science https://ift.tt/zVfaXCo
https://ift.tt/kFclm3b
from mint - science https://ift.tt/zVfaXCo
https://ift.tt/kFclm3b
إرسال تعليق